Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Camurati-Engelmann Syndrome × Drug Delivery Systems × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 4 Neoplasms 2 Glioma 2 Brain Neoplasms 2 Astrocytoma 2 Camurati-Engelmann Syndrome 1

Interventions

Trabedersen 1 Temozolomide 1 Lomustine 1 Drug Delivery Systems 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00431561 2013-12-03

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Isarna Therapeutics GmbH

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Camurati-Engelmann Syndrome, Glioblastoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡